In Q4 of fiscal 2024, the quarter ended Dec 31, 2024, Sonendo, Inc. used $2.9 million of cash from operations, up 69.1% from the same quarter a year earlier. It spent $0 on capital expenditures. Free cash flow was negative, at -$2.9 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.
| Line |
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
Q2 FY2024
Jun 30, 2024
|
Q1 FY2024
Mar 31, 2024
|
Q4 FY2023
Dec 31, 2023
|
Q3 FY2023
Sep 30, 2023
|
Q2 FY2023
Jun 30, 2023
|
Q1 FY2023
Mar 31, 2023
|
|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||
| Depreciation and amortization |
0
+212.5%
|
0
-80.2%
|
0
-80.3%
|
0
-81.1%
|
0
-92.2%
|
0
+43.8%
|
0
+60.6%
|
0
+37.8%
|
| Stock-based compensation |
1
-59.8%
|
1
-64.7%
|
1
-65.9%
|
3
+48.8%
|
1
-38.2%
|
2
+3.5%
|
2
+5.4%
|
2
+39.3%
|
| Operating cash flow |
-3
+69.1%
|
-4
+57.8%
|
-7
+28.3%
|
-11
+37.0%
|
-10
+33.3%
|
-10
+33.3%
|
-9
+30.4%
|
-17
+5.9%
|
| Investing | ||||||||
| Capital expenditures |
0
-100.0%
|
0
-100.0%
|
0
-96.4%
|
0
-30.5%
|
0
-73.5%
|
0
-8.9%
|
0
-43.5%
|
0
+275.0%
|
| Investing cash flow |
3
-75.7%
|
4
-55.1%
|
7
-28.6%
|
32
+168.1%
|
11
+131.4%
|
10
+434.0%
|
9
+126.2%
|
12
+21466.1%
|
| Financing | ||||||||
| Debt repaid |
3
|
3
|
3
|
17
|
—
|
—
|
—
|
—
|
| Financing cash flow |
-3
-271200.0%
|
-3
-2612.0%
|
-3
-2585.3%
|
-17
-280116.7%
|
0
+100.6%
|
-0
-100.1%
|
0
+2280.0%
|
-0
+98.8%
|
| Change in cash | ||||||||
| Net change in cash |
-3
-249.6%
|
-3
-446.5%
|
-3
-3451.9%
|
5
+191.1%
|
2
+103.8%
|
-0
-100.9%
|
-0
+99.8%
|
-5
+73.0%
|
| Free cash flow |
-3
+69.4%
|
-4
+58.7%
|
-7
+31.2%
|
-11
+37.0%
|
-10
+34.2%
|
-10
+33.0%
|
-10
+31.1%
|
-17
+5.1%
|
| Per share | ||||||||
| Free cash flow per share |
-6.19
+69.7%
|
-9.02
+59.2%
|
-0.07
+32.4%
|
-0.11
+37.9%
|
-20.41
-12919.9%
|
-22.13
-4609.6%
|
-0.10
+80.5%
|
-0.18
|
| Ratios | ||||||||
| Free cash flow margin |
-35.33%
|
-53.65%
|
-80.98%
|
-153.75%
|
-106.28%
|
-127.80%
|
-111.63%
|
-198.04%
|
| Capital expenditures to revenue |
0.00%
|
0.00%
|
0.18%
|
2.07%
|
0.95%
|
2.65%
|
4.76%
|
2.42%
|
| Stock-based compensation to revenue |
7.22%
|
7.84%
|
8.46%
|
41.01%
|
16.52%
|
21.85%
|
23.50%
|
22.38%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Dental Equipment & Supplies (SIC 3843)
- Listed as
- SONX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Laguna Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1407973
- Former names
- Dentatek CORP (until Dec 1, 2010)
Other Dental Equipment & Supplies companies
- Envista Holdings Corp NVST
- DENTSPLY SIRONA Inc. XRAY
- Dror Ortho-Design, Inc. DROR
- Standard Dental Labs Inc. TUTH
Source: SEC EDGAR filings. This is company-reported data, not investment advice.